The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD.
about
Adiponectin as a potential biomarker of vascular diseaseAdiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activityExercise reveals impairments in left ventricular systolic function in patients with metabolic syndromeDiastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosisEndothelial function in individuals with coronary artery disease with and without type 2 diabetes mellitus.Cardiac remodeling in obesity.Muscle as a secretory organ.Progranulin protects vascular endothelium against atherosclerotic inflammatory reaction via Akt/eNOS and nuclear factor-κB pathwaysSystemic adiponectin malfunction as a risk factor for cardiovascular diseaseC1q/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathwayBlunted flow-mediated responses and diminished nitric oxide synthase expression in lymphatic thoracic ducts of a rat model of metabolic syndrome.The diseasome of physical inactivity--and the role of myokines in muscle--fat cross talk.Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity.Cardiovascular risk in double diabetes mellitus--when two worlds collide.Extra-pancreatic effects of incretin-based therapies: potential benefit for cardiovascular-risk management in type 2 diabetes.Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase (AMPK) activation and IKK/NF-kappaB/PTEN suppressionGenetic Deletion of NADPH Oxidase 1 Rescues Microvascular Function in Mice With Metabolic Disease.Body mass index and blood pressure: where are we now?Integrated analysis of the gene expression profile and DNA methylation profile of obese patients with type 2 diabetes.The Inhibitory Effect of Ojeoksan on Early and Advanced Atherosclerosis
P2860
Q26821925-0AC464D3-F343-4168-9F2B-26A3B2B0A669Q28578061-B602AFFF-D028-44E1-A21C-23B823358E5AQ30421729-BCC04481-08E8-461A-8EE2-48205A6ECA6FQ33814148-E72A3208-EDD5-48C7-BDF2-A6E5135FB827Q33936833-BDC96F2A-B5D9-4C21-96EC-2D9C5ABD61D1Q34043589-F7259DB1-C3D8-4066-B13F-845648976DF4Q34360586-C9C189D3-0B9E-484F-A2AA-73208C3A1C51Q35010372-93C42260-5F5B-46B0-86FB-491837615DB4Q35173604-0DA04B5A-78B6-495A-9702-08FE01386D83Q35401905-ADB7BE70-90A4-4095-9F39-0168833A8046Q36699601-685ACE52-0DCC-4E95-8C98-3C4F3B29632CQ37596777-956EF2BD-062A-4CD6-8FB2-08426DC1EFCAQ37761303-A9848242-83DF-444B-B481-6624FC8B3491Q38001360-90FC22AC-B2EB-4F7D-9648-60ABC05B99CFQ38065321-C0810430-9501-4D13-AA31-14FA5E1A6B96Q39960657-CDD536B4-65CA-43B6-B009-288958B5E049Q46339542-9CFB265D-4E2C-409E-9469-2CCE3941D9E0Q46911841-0F74987C-3C07-419E-95D6-28AF832B2B74Q55007004-DDB9D3D2-D16A-4305-BF91-451A6ADA0677Q58760917-8B80DCAB-DF19-4491-93FF-D09FBC579B78
P2860
The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The metabolic syndrome and end ...... ay to type 2 diabetes and CVD.
@ast
The metabolic syndrome and end ...... ay to type 2 diabetes and CVD.
@en
type
label
The metabolic syndrome and end ...... ay to type 2 diabetes and CVD.
@ast
The metabolic syndrome and end ...... ay to type 2 diabetes and CVD.
@en
prefLabel
The metabolic syndrome and end ...... ay to type 2 diabetes and CVD.
@ast
The metabolic syndrome and end ...... ay to type 2 diabetes and CVD.
@en
P2860
P921
P1476
The metabolic syndrome and end ...... ay to type 2 diabetes and CVD.
@en
P2093
Maarten E Tushuizen
Michaela Diamant
P2860
P2888
P304
P356
10.1007/S11892-006-0061-4
P577
2006-08-01T00:00:00Z
P6179
1022262705